Zealand Pharma A/S (CPH:ZEAL)
Denmark · Delayed Price · Currency is DKK 238.00
+1.00 (0.42%)
Oct 9, 2026, 4:59 PM CET
Zealand Pharma Market Cap
Zealand Pharma has a market cap or net worth of 16.21 billion as of October 9, 2026. It is the 5,965th most valuable company in the world and the 30th biggest in Denmark. Its market cap has decreased by 54.85% in one year.
Market Cap
16.21B
Enterprise Value
2.17B
Revenue
4.64B
Global Rank
Country Rank
#30 Denmark
PE Ratio
6.18
ChartMarket Cap Chart
Since November 24, 2010, Zealand Pharma's market cap has increased from 1.41B to 16.21B, an increase of 1,053.22%. That is a compound annual growth rate of 16.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 16.21B | -50.65% |
| Dec 30, 2025 | 32.85B | -35.01% |
| Dec 30, 2024 | 50.55B | 132.03% |
| Dec 29, 2023 | 21.79B | 110.16% |
| Dec 30, 2022 | 10.37B | 65.31% |
| Dec 30, 2021 | 6.27B | -28.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.13T |
| Genmab | 146.10B |
| Coloplast | 98.15B |
| Demant | 71.96B |
| ALK-Abelló | 50.46B |
| H. Lundbeck | 45.13B |
| Ambu A/S | 19.02B |
| Bavarian Nordic | 17.93B |